Skip to content

Clinical trials

Phase 3 Obesity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Germany Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20063
20072
20101
20114
20121
20131
20161
20172
20186
20213
20225
20238
20244
202518
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting20
Recruiting20
Terminated7
Not yet recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S22
Eli Lilly and Company19
Amgen6
Boehringer Ingelheim5
Pfizer5
Sanofi4
Rhythm Pharmaceuticals, Inc.3
Ascletis Pharma (China) Co., Limited2
AstraZeneca2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity82
Overweight42
Diabetes Mellitus, Type 218
Nutrition Disorders7
Sleep Apnea, Obstructive6
Diabetes Mellitus5
Body Weight3
Overnutrition3
Cardiovascular Diseases2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.